Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-02

FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for carvedilol from Teva Pharmaceuticals USA, resulting in updated labeling. The approval confirms continued marketing o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)